HIV Clinic

Medicine & Life Sciences

1. HIV 100%
2. HIV-1 51%
3. Tuberculosis 49%
4. HIV Infections 32%
5. rifapentine 25%
6. GSK1265744 22%
7. efavirenz 22%
8. Virus Diseases 20%
9. Rilpivirine 19%
10. Therapeutics 19%
11. Isoniazid 18%
12. CD4 Lymphocyte Count 17%
13. Ritonavir 17%
14. Pharmacokinetics 16%
15. Multidrug-Resistant Tuberculosis 15%
16. Acquired Immunodeficiency Syndrome 14%
17. Magnetoencephalography 13%
18. RNA 12%
19. Clinical Trials 12%
20. Reverse Transcriptase Inhibitors 12%
21. Brain 11%
22. Neurocognitive Disorders 11%
23. Pharmaceutical Preparations 10%
24. Rifampin 10%
25. Protease Inhibitors 10%
26. Atazanavir Sulfate 9%
27. Moxifloxacin 9%
28. Nucleosides 9%
29. Viral Load 9%
30. AIDS Dementia Complex 9%
31. Cognitive Dysfunction 9%
32. Injections 8%
33. Pulmonary Tuberculosis 8%
34. Infections 7%
35. GS-7340 7%
36. Dementia 7%
37. Darunavir 7%
38. Pre-Exposure Prophylaxis 6%
39. Nevirapine 6%
40. Tenofovir 6%
41. Lopinavir 6%
42. Pharmacists 6%
43. Safety 6%
44. Midwestern United States 6%
45. Patient Protection and Affordable Care Act 5%
46. Mycobacterium tuberculosis 5%
47. Viruses 5%
48. Cross-Sectional Studies 5%
49. Latent Tuberculosis 5%
50. Coinfection 5%
51. Population 5%
52. Opportunistic Infections 5%
53. Drug Resistance 5%
54. Confidence Intervals 5%